Live
- Since YSRCP Boycotting Assembly Session: Alliance MLAs told to play Opposition role too
- Reliance invests big in AP
- 2024 on track to be hottest year on record
- PM Modi’s visit to Solapur: Women applaud ‘Double-Engine’ government’s initiatives
- Nagarkurnool MLA Dr. Kuchukulla Rajesh Reddy Campaigning in Maharashtra Elections
- Wife Kills Husband with Her Lover: Details of Veldanda Murder Case Revealed by SP Gaikwad
- Strict Action on Violations of Food Rights: Telangana Food Commission Chairman Goli Srinivas Reddy
- Smooth Conduct of Group-3 Exams with Strict Security Measures: Collector Badavath Santosh
- Delhi HC orders cancellation of LOC issued against Ashneer Grover, wife
- Shami’s absence a major blow for India in BGT, says Paul Adams
Natco Pharma Q2 profit plunges 35%
Highlights
Natco Pharma on Tuesday reported 35 per cent decline in consolidated net profit at Rs 117.7 crore for the quarter ended September 30, 2019.
Hyderabad: Natco Pharma on Tuesday reported 35 per cent decline in consolidated net profit at Rs 117.7 crore for the quarter ended September 30, 2019.
The Hyderabad-based company had posted a profit of Rs 181.1 crore in the year-ago period, Natco Pharma said. Total income stood at Rs 518.9 crore for the quarter under review as against Rs 583.5 crore in the year-ago period, a decline of 11 per cent, it added.
"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in the US and Hep C sales in India," Natco Pharma said.
Next Story
ADVERTISEMENT
